216 related articles for article (PubMed ID: 26040706)
1. Hospitalization and 1-year all-cause mortality in type 2 diabetic patients with chronic kidney disease at Stages 1 and 2: Effect of mild anemia.
Nseir W; Artul S; Nasrallah N; Mograbi J; Mahamid M
J Diabetes; 2016 Jul; 8(4):502-7. PubMed ID: 26040706
[TBL] [Abstract][Full Text] [Related]
2. Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease.
Sato Y; Fujimoto S; Konta T; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Narita I; Kondo M; Kasahara M; Shibagaki Y; Asahi K; Watanabe T
Clin Exp Nephrol; 2018 Apr; 22(2):388-394. PubMed ID: 28815319
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of anemia and chronic kidney disease in cancer patients: clinical significance for 1-year mortality].
Nakamura Y; Tsuchiya K; Nitta K; Ando M
Nihon Jinzo Gakkai Shi; 2011; 53(1):38-45. PubMed ID: 21370576
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease.
Salinero-Fort MÁ; San Andrés-Rebollo FJ; de Burgos-Lunar C; Abánades-Herranz JC; Carrillo-de-Santa-Pau E; Chico-Moraleja RM; Jiménez-García R; López-de-Andrés A; Gómez-Campelo P;
J Diabetes Complications; 2016 Mar; 30(2):227-36. PubMed ID: 26627635
[TBL] [Abstract][Full Text] [Related]
5. Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial.
Villar E; Lièvre M; Kessler M; Lemaître V; Alamartine E; Rodier M; François M; Zaoui P; Moranne O; Choukroun G; Guerraoui A; Jolivot A; Janin G; Branger B; Heng AE; Boudray C; Bissery A; Rabilloud M; Pouteil-Noble C
J Diabetes Complications; 2011; 25(4):237-43. PubMed ID: 21601481
[TBL] [Abstract][Full Text] [Related]
6. Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era.
Nauta ST; van Domburg RT; Nuis RJ; Akkerhuis M; Deckers JW
Kidney Int; 2013 Aug; 84(2):353-8. PubMed ID: 23486524
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease.
Awan AA; Walther CP; Richardson PA; Shah M; Winkelmayer WC; Navaneethan SD
Nephrol Dial Transplant; 2021 Jan; 36(1):129-136. PubMed ID: 31641775
[TBL] [Abstract][Full Text] [Related]
8. Low mean HbA1c does not increase all-cause and cardiovascular mortality in patients with diabetes: Effect-modifications by anemia and chronic kidney disease stages.
Ooi SW; Yeh ST; Chang YH; Li CY; Chen HF
PLoS One; 2022; 17(8):e0272137. PubMed ID: 35951657
[TBL] [Abstract][Full Text] [Related]
9. Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes.
Tseng CL; Lafrance JP; Lu SE; Soroka O; Miller DR; Maney M; Pogach LM
BMC Nephrol; 2015 Mar; 16():34. PubMed ID: 25885708
[TBL] [Abstract][Full Text] [Related]
10. [Impact of anemia and chronic kidney disease on the risk of cardiovascular disease and all-cause mortality among diabetic patients].
Yang C; Wang JW; Yang YZ; Bai KH; Gao BX; Zhao MH; Zhang LX; Wu SL; Wang F
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):495-500. PubMed ID: 29930419
[TBL] [Abstract][Full Text] [Related]
11. Vascular calcification in patients with nondialysis CKD over 3 years.
Górriz JL; Molina P; Cerverón MJ; Vila R; Bover J; Nieto J; Barril G; Martínez-Castelao A; Fernández E; Escudero V; Piñera C; Adragao T; Navarro-Gonzalez JF; Molinero LM; Castro-Alonso C; Pallardó LM; Jamal SA
Clin J Am Soc Nephrol; 2015 Apr; 10(4):654-66. PubMed ID: 25770175
[TBL] [Abstract][Full Text] [Related]
12. Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients.
Zoppini G; Targher G; Chonchol M; Negri C; Stoico V; Pichiri I; Lippi G; Muggeo M; Bonora E
Atherosclerosis; 2010 Jun; 210(2):575-80. PubMed ID: 20031129
[TBL] [Abstract][Full Text] [Related]
13. Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease.
Wagner M; Alam A; Zimmermann J; Rauh K; Koljaja-Batzner A; Raff U; Wanner C; Schramm L
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1573-9. PubMed ID: 21734083
[TBL] [Abstract][Full Text] [Related]
14. Anemia and early mortality in patients with decompensation of chronic heart failure.
Zairis MN; Patsourakos NG; Georgilas AT; Melidonis A; Argyrakis KS; Prekates AA; Mytas DZ; Karidis KS; Batika PC; Fakiolas CN; Foussas SG
Cardiology; 2011; 119(3):125-30. PubMed ID: 21912126
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
[TBL] [Abstract][Full Text] [Related]
16. Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study.
Yamamoto T; Miyazaki M; Nakayama M; Yamada G; Matsushima M; Sato M; Sato T; Taguma Y; Sato H; Ito S
Clin Exp Nephrol; 2016 Aug; 20(4):595-602. PubMed ID: 26519375
[TBL] [Abstract][Full Text] [Related]
17. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease and mortality risk among older patients with type 2 diabetes mellitus (ZODIAC-24).
Drion I; van Hateren KJ; Joosten H; Alkhalaf A; Groenier KH; Kleefstra N; Wetzels JF; Bilo HJ
Age Ageing; 2012 May; 41(3):345-50. PubMed ID: 22314695
[TBL] [Abstract][Full Text] [Related]
19. Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.
Xiong Z; Xu H; Huang X; Ärnlöv J; Qureshi AR; Cederholm T; Sjögren P; Lindholm B; Risérus U; Carrero JJ
Clin J Am Soc Nephrol; 2015 Apr; 10(4):584-91. PubMed ID: 25637632
[TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study.
Frimodt-Møller M; von Scholten BJ; Reinhard H; Jacobsen PK; Hansen TW; Persson FI; Parving HH; Rossing P
PLoS One; 2018; 13(4):e0196634. PubMed ID: 29698460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
